371 related articles for article (PubMed ID: 17202109)
1. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
2. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
3. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
4. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
5. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
[TBL] [Abstract][Full Text] [Related]
6. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Chang S; Long SR; Kutikova L; Bowman L; Finley D; Crown WH; Bennett CL
J Clin Oncol; 2004 Sep; 22(17):3524-30. PubMed ID: 15337801
[TBL] [Abstract][Full Text] [Related]
7. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
[TBL] [Abstract][Full Text] [Related]
8. Time costs associated with informal caregiving for cancer survivors.
Yabroff KR; Kim Y
Cancer; 2009 Sep; 115(18 Suppl):4362-73. PubMed ID: 19731345
[TBL] [Abstract][Full Text] [Related]
9. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
Yabroff KR; Mariotto AB; Feuer E; Brown ML
Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
11. The economic effect of a tertiary hospital-based heart failure program.
Gregory D; DeNofrio D; Konstam MA
J Am Coll Cardiol; 2005 Aug; 46(4):660-6. PubMed ID: 16098432
[TBL] [Abstract][Full Text] [Related]
12. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years.
Pollack LA; Adamache W; Ryerson AB; Eheman CR; Richardson LC
Cancer; 2009 Nov; 115(22):5284-95. PubMed ID: 19685532
[TBL] [Abstract][Full Text] [Related]
13. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
14. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
Ward EM; Fedewa SA; Cokkinides V; Virgo K
Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
[TBL] [Abstract][Full Text] [Related]
15. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
Ramsey SD; Berry K; Etzioni R
Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
[TBL] [Abstract][Full Text] [Related]
16. Clinical model of cost of bladder cancer in the elderly.
Cooksley CD; Avritscher EB; Grossman HB; Sabichi AL; Dinney CP; Pettaway C; Elting LS
Urology; 2008 Mar; 71(3):519-25. PubMed ID: 18342201
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
18. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
20. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
